Stoke Therapeutics, Inc.STOKNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+117.9%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

5Y CAGR
+117.9%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
49.1x
Strong expansion
Streak
4 yr
Consecutive growthAccelerating
PeriodValue
202592.73%
202430.67%
20238.46%
2022-11.11%
2021-50.00%
20201.89%
2019-200.00%
2018-120.83%
20170.00%